Perovskite solar cells (PSCs) based on the regular n–i–p device architecture have reached
above 25% certified efficiency with continuously reported improvements in recent years. A …

Anticancer nanomedicines have been proven effective in mitigating the side effects of
chemotherapeutic drugs. However, challenges remain in augmenting their therapeutic …

Effective anticancer nanomedicines need to exhibit prolonged circulation in blood, to
extravasate and accumulate in tumours, and to be taken up by tumour cells. These …

The antitumor efficiency and clinical translation of traditional nanomedicines is mainly
restricted by low drug loading, complex preparation technology, and potential toxicity …

As immunogenic cell death (ICD) inducers initiating antitumor immune responses, certain
chemotherapeutic drugs have shown considerable potential to reverse the …

In recent years, due to the limitations of the nature of therapeutic agents, many synthetic
nano-delivery systems have emerged to enhance the efficacy of drugs. Extracellular vesicles …

A stimuli‐responsive polymeric prodrug‐based nanotheranostic system with imaging agents
(cyanine5. 5 and gadolinium‐chelates) and a therapeutic agent paclitaxel (PTX) is prepared …

In the last few decades, we have witnessed the great advances of molecular self-assembly
in biomedical applications. Among the building blocks for molecular self-assembly, peptide …

The research on advanced functional polymers is being driven by the fast-growing demand
for new functional materials that can be used in revolutionary technologies. Polymers can be …

In recent years, tremendous advancements in nanomedicine have resulted in the rapid
development of various nanoformulations, especially the treatment of solid tumors. Despite …